These results verified that in human CRC cells, MCPIP3 can change EMT-related gene expressions to inhibit cancer cell migration and invasion, and the RNase activity of MCPIP3 might be not involved in the regulation of E-cadherin and vimentin expression. The gene discussed is CDH1; the disease is colorectal carcinoma.